C-X-C Motif Chemokine Ligand 16 Is a Potent Predictor of Outcomes in Dialysis Patients

被引:1
|
作者
Liu, Wenjin [1 ]
Wang, Lulu [2 ]
Li, Xiurong [3 ]
Gao, Chaoqing [4 ]
Zhou, Jianmei [4 ]
Zhou, Jiajun [4 ]
Wang, Liang [5 ]
Sun, Zhuxing [5 ]
Chu, Hong [6 ]
Fan, Wei [6 ]
Bai, Youwei [7 ]
Yang, Junwei [2 ]
机构
[1] Univ Utah Hlth Sci, Dept Internal Med, Div Nephrol & Hypertens, Salt Lake City, UT USA
[2] Nanjing Med Univ, Ctr Kidney Dis, Affiliated Hosp 2, Nanjing, Peoples R China
[3] Soochow Univ, Dept Nephrol, Affiliated Hosp 3, Changzhou, Peoples R China
[4] Wannan Med Coll, Dept Hemodialysis, Yijishan Hosp, Wuhu, Peoples R China
[5] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Nephrol, Wuxi, Jiangsu, Peoples R China
[6] Jiangsu Univ, Affiliated Yixing Peoples Hosp, Dept Nephrol, Yixing, Peoples R China
[7] Luan Peoples Hosp, Dept Nephrol, Luan, Peoples R China
关键词
C-X-C motif chemokine ligand; Dialysis; Inflammation; Biomarker; Kidney disease; REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; KIDNEY-FUNCTION; SOLUBLE CXCL16; MORTALITY; HEMODIALYSIS; INFLAMMATION; RISK; ATHEROSCLEROSIS; CARDIOMYOPATHY;
D O I
10.1159/000518400
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: C-X-C motif chemokine ligand 16 (CXCL16) is an inflammatory marker that has been found to be predictive of outcomes in patients with cardiovascular disease. Our previous work has also demonstrated its relation to cardiac injury in dialysis patients. However, it is yet unclear whether there is an association between CXCL16 and adverse outcomes in dialysis patients. We aimed to evaluate its prognostic value along with several traditional inflammatory markers in the current study. Methods: This is a multicenter longitudinal study of prevalent dialysis patients. Circulating inflammatory markers including CXCL16, C-reactive protein (CRP), tumor necrosis factor-alpha, and interleukin-6 (IL-6) were measured using a multiplex assay. The primary outcomes were all-cause mortality and a composite of major adverse cardiovascular events (MACEs). The associations between biomarkers and outcomes were analyzed using Cox proportional hazards regression models. Results: Of the 366 participants with available plasma samples, the average age was 52.5 (+/- 12.1) years, and there were 160 (43.7%) female participants. For all-cause mortality, logarithmically transformed CXCL16, IL-6, and CRP were independent predictors after adjustment for covariates. When the 3 markers were included in the same model, CXCL16 was the only one remaining its significance. For MACEs, logarithmically transformed CXCL16 and IL-6 were significant predictors when analyzed separately and CXCL16 was an independent predictor even after adjustment for IL-6. When the biomarkers were analyzed as categorical variables, only CXCL16 was associated with both outcomes. Adding CXCL16 to established risk factors improved risk prediction as revealed by Net Reclassification Index (NRI). Conclusion: Using a multimarker approach, we determined that CXCL16 is a potent predictor of all-cause mortality and cardiovascular events in dialysis patients. Our data suggest CXCL16 may improve risk stratification and could be a potential interventional target.
引用
收藏
页码:725 / 734
页数:10
相关论文
共 50 条
  • [21] C-X-C receptor 7 agonist acts as a C-X-C motif chemokine ligand 12 inhibitor to ameliorate osteoclastogenesis and bone resorption
    Nugraha, Alexander Patera
    Kitaura, Hideki
    Ohori, Fumitoshi
    Pramusita, Adya
    Ogawa, Saika
    Noguchi, Takahiro
    Marahleh, Aseel
    Nara, Yasuhiko
    Kinjo, Ria
    Mizoguchi, Itaru
    MOLECULAR MEDICINE REPORTS, 2022, 25 (03)
  • [22] Role of C-X-C chemokine ligand 12/C-X-C chemokine receptor 4 in the progression of hepatocellular carcinoma
    Jeng, Kuo-Shyang
    Jeng, Chi-Juei
    Jeng, Wen-Juei
    Chang, Chiung-Fang
    Sheen, I-Shyan
    ONCOLOGY LETTERS, 2017, 14 (02) : 1905 - 1910
  • [23] C-X-C motif chemokine ligand 1 and its receptor C-X-C motif chemokine receptor 2 in trigeminal ganglion contribute to nerve injury-induced orofacial mechanical allodynia
    Yang, Jie
    Liu, Fei
    Zhang, Yan-Yan
    Lin, Jiu
    Li, Yue-Ling
    Zhou, Cheng
    Li, Chun-Jie
    Shen, Jie-Fei
    JOURNAL OF ORAL REHABILITATION, 2022, 49 (02) : 195 - 206
  • [24] Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer
    Zhuo, Changhua
    Wu, Xianyi
    Li, Jing
    Hu, Dan
    Jian, Jinliang
    Chen, Changjiang
    Zheng, Xiongwei
    Yang, Chunkang
    BIOSCIENCE REPORTS, 2018, 38
  • [25] HIGH CIRCULATING CHEMOKINES (C-X-C MOTIF) LIGAND 9, AND (C-X-C MOTIF) LIGAND 11, IN HEPATITIS C-ASSOCIATED CRYOGLOBULINEMIA
    Antonelli, A.
    Fallahi, P.
    Ferrari, S. M.
    Frascerra, S.
    Mancusi, C.
    Colaci, M.
    Manfredi, A.
    Sansonno, D.
    Zignego, A. L.
    Ferri, C.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2013, 26 (01) : 49 - 57
  • [26] Role of Chemokine (C-X-C Motif) Ligand 10 (CXCL10) in Renal Diseases
    Gao, Jie
    Wu, Lingling
    Wang, Siyang
    Chen, Xiangmei
    MEDIATORS OF INFLAMMATION, 2020, 2020
  • [27] Antitumor efficacy of C-X-C motif chemokine ligand 14 in hepatocellular carcinoma in vitro and in vivo
    Wang, Weilin
    Huang, Pengfei
    Zhang, Lufei
    Wei, Jianfeng
    Xie, Qingsong
    Sun, Qiang
    Zhou, Xiaohu
    Xie, Haiyang
    Zhou, Lin
    Zheng, Shusen
    CANCER SCIENCE, 2013, 104 (11) : 1523 - 1531
  • [28] C-X-C motif chemokine ligand 12: a potential therapeutic target in Duchenne muscular dystrophy
    Chen, Jie
    Lai, Xinsheng
    BIOENGINEERED, 2021, 12 (01) : 5428 - 5439
  • [29] Progestin regulates chemokine (C-X-C motif) ligand 14 transcript level in human endometrium
    Mokhtar, Norfilza M.
    Cheng, Ching-wen
    Cook, Emma
    Bielby, Holli
    Smith, Stephen K.
    Charnock-Jones, D. Stephen
    MOLECULAR HUMAN REPRODUCTION, 2010, 16 (03) : 170 - 177
  • [30] Collagen content and C-X-C motif chemokine ligand 12 expression in neoplastic breast stroma
    Ferreira, Cindy Juliane da Silva
    Caires, Inacelli Queiroz de Souza
    Neto, Walfrido Jose Bezerra da Costa
    de Almeida, Sinara Monica Vitalino
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2023, 69 (09):